Σεπτέμβριος 2016

Retrofitting public buildings is crucial to meeting Europe’s energy efficiency goals. But can new knowledge in retrofitting be replicated across the EU?

The move to energy efficient buildings is on. Two European directives are gently nudging things along, by requiring that 3% of public buildings be renovated every year and that public buildings be almost energy zero by 2018.

A consortium of European researchers called BRICKER are trying to nail down the challenging combination of retrofitted technologies to suit different public buildings in different climates.

Heidelberg, 5 September 2016 - The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors. This suggests CHD1 as a potential biomarker for targeted prostate cancer therapy. These are the results of a study published today in EMBO reports.

Oppla is a new knowledge marketplace; a place where the latest thinking on nature-based solutions is brought together from across Europe. Oppla will provide a platform for collaboration between communities of science, policy and practice – matching the knowledge of experts with the needs of practitioners through an innovative new ‘question and answer’ service: Ask Oppla.

For Parkinson’s disease (PD) patients whose symptoms cannot be controlled by medication, ‘Deep brain stimulation’ (DBS) may be the only hope. While DBS is generally considered to be safe, side effects related to the stimulation may occur in some cases, including numbness or tingling sensations, muscle tightness, speech or balance problems and unwanted mood changes. The IMPACT project has set out to counter these side-effects by bringing DBS to the next level.